MX9405110A - Nuevos derivados de (1-heteroazolil-1-heterociclil)alcano y su uso comoagentes neuroprotectores. - Google Patents
Nuevos derivados de (1-heteroazolil-1-heterociclil)alcano y su uso comoagentes neuroprotectores.Info
- Publication number
- MX9405110A MX9405110A MX9405110A MX9405110A MX9405110A MX 9405110 A MX9405110 A MX 9405110A MX 9405110 A MX9405110 A MX 9405110A MX 9405110 A MX9405110 A MX 9405110A MX 9405110 A MX9405110 A MX 9405110A
- Authority
- MX
- Mexico
- Prior art keywords
- lower alkyl
- ring
- arylalkyl
- compounds
- independently
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención se relaciona con compuestos heterocíclicos novedososque tienen la fórmula general (I) en la que: X es O, S, Se o NR2; Y1, Y2,Y3, Y4 son independientemente N o CR2; Z es O, S, Se, NR2 o C = N; R1 esuno o más grupos seleccionados de H, alquilo inferior, acilo inferior,halógeno, alcoxi inferior o CF3, o R1 y el anillo juntos representan unanillo benzo fusionado opcionalmente sustituido de manera adicional; R2 esH, alquilo inferior, alcoxi inferior-alquilo inferior, hidroxialquiloinferior, aciloxi inferior-alquilo inferior, arilalquilo inferior o CF3, ycuando más de uno de los grupos R2 está presente, estos se puedenseleccionar independientemente; y A es en el que W es O, S, NH o N-alquiloinferior, R3 es H, alquilo inferior o acilo inferior, R4 es alquiloinferior, arilalquilo inferior, ciclopropilo o perfluoroalquilo inferior,o R3 y R4 juntos forman un anillo en el que n es 2, 3 ó 4, R5 y R6 sonindependientemente H, alquilo inferior o arilalquilo inferior; con lacondición de que por lo menos uno de X, Y1, Y2, Y3, o Y4 es nitrógeno enel que el anillo no es 1-metil-2-imidazolilo; los isómeros geométricos yópticos y racematos de los mismos en los que tales isómeros existan, asícomo las sales de adición de ácido farmacéuticamente aceptables de losmismos y solvatos de los mismos; que tienen actividad terapéutica,procesos intermediarios para su preparación, formulaciones farmacéuticasque contienen tales compuestos y el uso medicinal de tales compuestos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE19939302332A SE9302332D0 (sv) | 1993-07-06 | 1993-07-06 | New compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9405110A true MX9405110A (es) | 1995-01-31 |
Family
ID=20390539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9405110A MX9405110A (es) | 1993-07-06 | 1994-07-05 | Nuevos derivados de (1-heteroazolil-1-heterociclil)alcano y su uso comoagentes neuroprotectores. |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US5731335A (es) |
| EP (1) | EP0707584A1 (es) |
| JP (1) | JPH08512312A (es) |
| CN (1) | CN1126994A (es) |
| AU (1) | AU691506B2 (es) |
| BR (1) | BR9406923A (es) |
| CA (1) | CA2164856A1 (es) |
| CZ (1) | CZ5396A3 (es) |
| EE (1) | EE03193B1 (es) |
| EG (1) | EG20569A (es) |
| FI (1) | FI960076A (es) |
| HU (1) | HUT75097A (es) |
| IL (1) | IL110157A (es) |
| IS (1) | IS4182A (es) |
| MX (1) | MX9405110A (es) |
| NO (1) | NO305955B1 (es) |
| NZ (1) | NZ268689A (es) |
| PL (1) | PL176471B1 (es) |
| RU (1) | RU2124011C1 (es) |
| SE (1) | SE9302332D0 (es) |
| SG (1) | SG64891A1 (es) |
| SK (1) | SK159895A3 (es) |
| WO (1) | WO1995001979A1 (es) |
| ZA (1) | ZA944569B (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9604242D0 (en) | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
| DE19645313A1 (de) | 1996-11-04 | 1998-05-07 | Basf Ag | Substituierte 3-Benzylpyrazole |
| EP1047423B1 (en) | 1997-11-19 | 2006-05-10 | Takeda Pharmaceutical Company Limited | Novel apoptosis inhibitors |
| AR035016A1 (es) | 1999-08-25 | 2004-04-14 | Takeda Chemical Industries Ltd | Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima. |
| JP5132861B2 (ja) * | 2000-03-24 | 2013-01-30 | ユーロ−セルティック エス． ア． | ナトリウムチャネル遮断薬としてのアリール置換ピラゾール、トリアゾールおよびテトラゾール |
| EP1709019B1 (en) | 2004-01-12 | 2007-08-08 | Applied Research Systems ARS Holding N.V. | Thiazole derivatives and use thereof |
| EP1794167A4 (en) * | 2004-09-10 | 2009-10-21 | Syngenta Ltd | SUBSTITUTED ISOXAZOLE AS FUNGICIDES |
| US7888376B2 (en) * | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| CA2687973C (en) * | 2007-05-23 | 2015-04-07 | Allergan, Inc. | ((bicylicheteroaryl) imidazolyl)methylheteroaryl compounds as adrenergic receptor agonists |
| WO2009123164A1 (ja) * | 2008-04-02 | 2009-10-08 | 塩野義製薬株式会社 | 血管内皮リパーゼ阻害活性を有するヘテロ環誘導体 |
| CN103003268A (zh) * | 2010-07-19 | 2013-03-27 | 先正达参股股份有限公司 | 作为杀微生物剂的异噁唑、异噻唑、呋喃以及噻吩化合物 |
| EP2447261A1 (en) * | 2010-10-29 | 2012-05-02 | Basf Se | Pyrrole, furane and thiophene derivatives and their use as fungicides |
| WO2013033004A2 (en) * | 2011-08-30 | 2013-03-07 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58150576A (ja) * | 1982-03-03 | 1983-09-07 | Sumitomo Chem Co Ltd | 新規な１，２，４−オキサジアゾ−ル誘導体 |
| JPH01249760A (ja) * | 1988-03-29 | 1989-10-05 | Yamaha Corp | ホトクロミック化合物 |
| US5068237A (en) * | 1990-05-21 | 1991-11-26 | Warner-Lambert Company | Substituted furans and derivatives thereof acting at muscarinic receptors |
| AU3171493A (en) * | 1991-12-31 | 1993-07-28 | Fujisawa Pharmaceutical Co., Ltd. | Oxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activity |
-
1993
- 1993-07-06 SE SE19939302332A patent/SE9302332D0/xx unknown
-
1994
- 1994-06-23 IS IS4182A patent/IS4182A/is unknown
- 1994-06-24 ZA ZA944569A patent/ZA944569B/xx unknown
- 1994-06-29 IL IL11015794A patent/IL110157A/xx not_active IP Right Cessation
- 1994-07-05 CN CN94192713A patent/CN1126994A/zh active Pending
- 1994-07-05 NZ NZ268689A patent/NZ268689A/en unknown
- 1994-07-05 BR BR9406923A patent/BR9406923A/pt not_active Application Discontinuation
- 1994-07-05 US US08/379,506 patent/US5731335A/en not_active Expired - Fee Related
- 1994-07-05 EP EP94921147A patent/EP0707584A1/en not_active Withdrawn
- 1994-07-05 CZ CZ9653A patent/CZ5396A3/cs unknown
- 1994-07-05 AU AU71977/94A patent/AU691506B2/en not_active Ceased
- 1994-07-05 HU HU9503744A patent/HUT75097A/hu unknown
- 1994-07-05 SK SK1598-95A patent/SK159895A3/sk unknown
- 1994-07-05 SG SG1996005493A patent/SG64891A1/en unknown
- 1994-07-05 MX MX9405110A patent/MX9405110A/es not_active IP Right Cessation
- 1994-07-05 CA CA002164856A patent/CA2164856A1/en not_active Abandoned
- 1994-07-05 WO PCT/SE1994/000663 patent/WO1995001979A1/en not_active Application Discontinuation
- 1994-07-05 PL PL94312417A patent/PL176471B1/pl unknown
- 1994-07-05 RU RU96103659A patent/RU2124011C1/ru active
- 1994-07-05 JP JP7503998A patent/JPH08512312A/ja active Pending
- 1994-07-06 EG EG40594A patent/EG20569A/xx active
- 1994-11-23 EE EE9400387A patent/EE03193B1/xx unknown
-
1995
- 1995-06-02 US US08/459,847 patent/US5607956A/en not_active Expired - Fee Related
-
1996
- 1996-01-04 NO NO960028A patent/NO305955B1/no not_active IP Right Cessation
- 1996-01-08 FI FI960076A patent/FI960076A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1995001979A1 (en) | 1995-01-19 |
| NO960028L (no) | 1996-02-27 |
| FI960076A0 (fi) | 1996-01-08 |
| BR9406923A (pt) | 1996-07-30 |
| HUT75097A (en) | 1997-04-28 |
| PL176471B1 (pl) | 1999-06-30 |
| CN1126994A (zh) | 1996-07-17 |
| CA2164856A1 (en) | 1995-01-19 |
| SG64891A1 (en) | 1999-05-25 |
| EE03193B1 (et) | 1999-06-15 |
| RU2124011C1 (ru) | 1998-12-27 |
| IL110157A0 (en) | 1994-10-07 |
| IL110157A (en) | 2000-01-31 |
| SE9302332D0 (sv) | 1993-07-06 |
| HU9503744D0 (en) | 1996-02-28 |
| US5731335A (en) | 1998-03-24 |
| CZ5396A3 (en) | 1996-06-12 |
| IS4182A (is) | 1995-01-07 |
| PL312417A1 (en) | 1996-04-15 |
| EG20569A (en) | 1999-08-30 |
| FI960076A (fi) | 1996-01-08 |
| ZA944569B (en) | 1995-02-15 |
| AU7197794A (en) | 1995-02-06 |
| SK159895A3 (en) | 1996-09-04 |
| NO960028D0 (no) | 1996-01-04 |
| AU691506B2 (en) | 1998-05-21 |
| JPH08512312A (ja) | 1996-12-24 |
| NO305955B1 (no) | 1999-08-23 |
| NZ268689A (en) | 1997-11-24 |
| EP0707584A1 (en) | 1996-04-24 |
| US5607956A (en) | 1997-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9405110A (es) | Nuevos derivados de (1-heteroazolil-1-heterociclil)alcano y su uso comoagentes neuroprotectores. | |
| ES2187983T3 (es) | Derivados 1,2,3,4-tetrahidronaftaleno sustituidos. | |
| UA72917C2 (en) | Cyclic carbamates derivatives, pharmaceutical composition containing said derivatives of cyclic carbamates and active ingredients as modulators of the progesterone receptor | |
| HUP0301389A2 (hu) | Purinszármazékok | |
| AR051202A1 (es) | Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa | |
| UY27336A1 (es) | Derivados de 4-piperacinilindol con afinidad receptora de 5-ht6 | |
| AR020727A1 (es) | Uso de compuestos derivados 3-amino-4-aril-maleimidas para la preparacion de medicamentos para condiciones asociadas a una necesidad de inhibicion de lagsk-3, dichos compuestos, procedimiento para su preparacion y composiciones farmaceuticas que los comprenden | |
| ES2123829T3 (es) | Derivados de 3-(5-tetrazolil-bencil)amino-piperidina y antagonistas de las taquiquininas. | |
| PE20030759A1 (es) | Uso de ureas de benzotiazoles | |
| AR047557A1 (es) | Compuestos derivados de piridazina y su uso como agentes terapeuticos | |
| AR016817A1 (es) | Derivados de fenilurea o feniltiourea, procedimiento para su preparacion, coleccion de compuestos, compuestos intermediarios, composicion farmaceutica,metodo de tratamiento y uso de dichos compuestos para la manufactura de un medicamento | |
| HUP0203872A2 (hu) | Helyettesített 4-(fenil-N-alkil)-piperazin és piperidinszármazékok, alkalmazásuk dopamin neurotranszmissziós modulátorként és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0004564A2 (hu) | Gasztrokinetikus hatású 3- vagy 4-szubsztituált 4-(aminometil)-piperidin-származékok monociklusos benzamidjai, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények | |
| MXPA05011710A (es) | Derivados de pirimidina con actividad de crf. | |
| DK526188D0 (da) | Benzimidazolin-2-oxo-1-carboxylsyrederivater til anvendelse som 5-ht receptorantagonister i farmaceutiske praeparater | |
| AR038249A1 (es) | Compuestos derivados de quinolina, procedimientos para su preparacion, composiciones farmaceuticas que los comprenden, y uso de dichos compuestos derivados en la preparacion de un medicamento | |
| DK0649418T3 (da) | 7-(2-aminoethyl)benzothiazolon | |
| BG94282A (bg) | 2,9-дизаместени-4н-пиридо/1,2,-а/пиримидин-4-они | |
| AR034174A1 (es) | Compuestos de benzoxazinona, procedimiento para su preparacion, composiciones farmaceuticas que lo comprenden, procedimiento para la preparacion de tales composiciones, y el uso de dichos compuestos o composiciones en la fabricacion de medicamentos | |
| SE9703378D0 (sv) | New compounds | |
| AR007108A1 (es) | Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes. | |
| CO5160261A1 (es) | Derivados de bifenilo sustituidos que son antagonistas nk-1, su procedimiento de sintesis y composiciones farmaceuticas que los contienen | |
| ES2064341T3 (es) | Nuevas n-(3-hidroxi-4-piperidinil)benzamidas sustituidas. | |
| AR031486A1 (es) | Derivados de pirimidina | |
| AR019256A1 (es) | Utilizacion de derivados tetraciclo[6-6-2-0(2.27).0(9.14)] hexadeca-2(7), 3, 5, 9(14), 10,12-hexaeno, para la preparacion de preparados farmaceuticos conaccion inhibitoria de la fosfolipasa, los referidos derivados y preparado farmaceutico que contiene por lo menos a uno de dichos derivados |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| MM | Annulment or lapse due to non-payment of fees |